Detalhe da pesquisa
1.
Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy.
Int J Cancer
; 154(12): 2142-2150, 2024 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38447003
2.
Neoadjuvant and adjuvant approaches in gastroesophageal cancers.
Curr Opin Oncol
; 35(4): 318-325, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37222198
3.
Programmed Cell Death Protein 1 Blockade Elicits Ongoing Remission in 2 Cases of Refractory Epstein-Barr Virus-Associated Metastatic Gastric Carcinoma.
Oncol Res Treat
; 45(6): 375-379, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35220300
4.
PD-1 Blockade Elicits Ongoing Remission in Two Cases of Refractory Microsatellite-Stable Cancer Harboring a POLE Mutation.
Oncol Res Treat
; 45(4): 222-226, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34875656
5.
[Modern concepts of systemic treatment for adjuvant and palliative treatment of locally advanced or metastasized esophageal cancer]. / Moderne Konzepte der Systemtherapie zur adjuvanten und palliativen Behandlung des lokal fortgeschrittenen oder metastasierten Ösophaguskarzinoms.
Chirurg
; 92(12): 1085-1093, 2021 Dec.
Artigo
em Alemão
| MEDLINE | ID: mdl-34387700